Botswana study investigates tamoxifen adherence in breast cancer patients
NCT ID NCT06660030
First seen Jan 09, 2026 · Last updated Jun 05, 2026 · Updated 20 times
Summary
This study looked at why women with breast cancer in Botswana might stop taking tamoxifen, a key hormone therapy. Researchers focused on side effects, quality of life, and HIV status as possible reasons. The study included 10 women, both with and without HIV, to understand barriers to sticking with treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Marina Hospital
Gaborone, 267, Botswana
Conditions
Explore the condition pages connected to this study.